Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Glennon Small Companies Ltd ( (AU:GC1) ) just unveiled an announcement.
Glennon Small Companies Ltd’s portfolio showed strong performance in January 2025, with a return of 4.66%, slightly outperforming its benchmark index. Significant contributors to this performance included Telix Pharmaceuticals and Pro Medicus, driven by strategic acquisitions and contract gains. Meanwhile, Zip Co’s higher-than-expected costs impacted its stock negatively. The portfolio’s 12-month return of 27.35% reflects its robust growth against the benchmark’s 12.32%, indicating a positive impact on the company’s market positioning.
More about Glennon Small Companies Ltd
Glennon Small Companies Ltd operates in the investment industry, focusing on small companies. The company manages a portfolio that includes various sectors such as pharmaceuticals, technology, and resources. Its primary market focus is on identifying and investing in promising small-cap companies with potential for growth.
YTD Price Performance: -2.08%
Average Trading Volume: 28,503
Technical Sentiment Consensus Rating: Buy
Learn more about GC1 stock on TipRanks’ Stock Analysis page.